PSCA Antibody (YA5511)
PSCA Antibody (YA5511) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to PSCA.
-
Host:
Mouse
-
Isotype:
IgG2b
-
Application:
WB, ICC/IF, ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|
| Dilution Ratio | 1:500-2000 | 1:100-500 | 1:1000-5000 |
Product Details
PSCA Antibody (YA5511) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to PSCA.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
-
Observed Molecular WeightObserved band size: 18 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 13 kDa
Synthesized peptide derived from human PSCA AA range: 1-100
Protein G
Non-conjugated
Unmodified
IgG2b
Product Properties
-
Appearance
Liquid
-
Formulation
Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
PSCA may be involved in the regulation of cell proliferation. Has a cell-proliferation inhibition activity in vitro; May act as a modulator of nicotinic acetylcholine receptors (nAChRs) activity. In vitro inhibits nicotine-induced signaling probably implicating alpha-3:beta-2- or alpha-7-containing nAChRs
-
Subcellular Localization
Cell membrane; Lipid-anchor, GPI-anchor
-
Expression
Tissue_specificity:It is highly expressed in the prostate (basal epithelial cells, secretory epithelial cells, and neuroendocrine epithelial cells) . It is also found in the bladder (transitional epithelium) , placenta (trophoblast cells) , stomach (neuroendocrine cells) , colon (neuroendocrine cells) , and kidney (collecting ducts) . It is overexpressed in prostate cancer, and its expression is correlated with tumor stage, grade, and androgen-independent characteristics. It is highly expressed in bone metastases of prostate cancer. It is expressed in gastric epithelial cells, primarily in the gastric isthmus (protein level) . It is not detected in normal intestinal epithelium (protein level) . It is expressed in the cerebral cortex; its expression is significantly increased in the prefrontal cortex of Alzheimer's disease patients.
Induction:Down-regulated in gastric cancer cells -
Subunit
Interacts with CHRNA4
-
SwissProt ID
Documentation